Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens.

Arsenic (As) is environmentally ubiquitous and an epidemiologically significant chemical related to certain human cancers. Dimethylarsinic acid (cacodylic acid; DMA) is one of the major methylated metabolites of ingested arsenicals in most mammals. To evaluate the effects of DMA on chemical carcinogenesis, we conducted a multiorgan bioassay in rats given various doses of DMA. One-hundred twenty-four male F344/DuCrj rats were divided randomly into 7 groups (20 rats each for groups 1-5; 12 rats each for groups 6 and 7). To initiate multiple organs and tissues, animals in groups 1-5 were treated sequentially with diethylnitrosamine (100 mg/kg body weight, i.p., single dose at the commencement) and N-methyl-N-nitrosourea (20 mg/kg body weight, i.p., 4 times, on days 5, 8, 11, and 14). Thereafter, rats received 1,2-dimethylhydrazine (40 mg/kg body weight, s.c., 4 times, on days 18, 22, 26, and 30). During the same period, the animals were sequentially administered N-butyl-N-(4-hydroxybutyl)nitrosamine (0.05% in the drinking water, during weeks 1 and 2) and N-bis(2-hydroxypropyl)nitrosamine (0.1% in the drinking water, during weeks 3 and 4; DMBDD treatment). After a 2-week interval, groups 2-5 were given 50, 100, 200, or 400 ppm DMA, respectively, in the drinking water. Groups 6 and 7, which were not given DMBDD treatment, received 100 and 400 ppm DMA during weeks 6-30. All rats were killed at the end of week 30. In the initiated groups (groups 1-5), DMA significantly enhanced the tumor induction in the urinary bladder, kidney, liver, and thyroid gland, with respective incidences in group 5 (400 ppm DMA) being 80, 65, 65, and 45%. Induction of preneoplastic lesions (glutathione S-transferase placental form-positive foci in the liver and atypical tubules in the kidney) was also significantly increased in DMA-treated groups. Ornithine decarboxylase activity in the kidneys of rats treated with 100 ppm DMA was significantly increased compared with control values (P < 0.001). In conclusion, DMA is acting as a promoter of urinary bladder, kidney, liver, and thyroid gland carcinogenesis in rats, and we speculate that this may be related to cancer induction by As in humans.

[1]  Y. Inoue,et al.  Determination of arsenic compounds using inductively coupled plasma mass spectrometry with ion chromatography , 1994 .

[2]  Y. Inoue,et al.  Determination of arsenic species by inductively coupled plasma mass spectrometry with ion chromatography , 1994 .

[3]  J. Dong,et al.  Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. , 1993, Mutation research.

[4]  S. Fukushima,et al.  Spermidine/Spermine N‐Acetyltransferase, a New Biochemical Marker for Epithelial Proliferation in Rat Bladder , 1992, Japanese journal of cancer research : Gann.

[5]  A. Smith,et al.  Arsenic ingestion and internal cancers: a review. , 1992, American journal of epidemiology.

[6]  S. Fukushima,et al.  Modifying Effects of Various Chemicals on Preneoplastic and Neoplastic Lesion Development in a Wide‐spectrum Organ Carcinogenesis Model Using F344 Rats , 1991, Japanese journal of cancer research : Gann.

[7]  S. Okada,et al.  Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. , 1991, Toxicology and applied pharmacology.

[8]  B. Fowler,et al.  Alteration in protein synthesis in primary cultures of rat kidney proximal tubule epithelial cells by exposure to gallium, indium, and arsenite. , 1990, Toxicology and applied pharmacology.

[9]  C. J. Chen,et al.  Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. , 1990, Cancer research.

[10]  L. Ellwein,et al.  Cell proliferation in carcinogenesis. , 1990, Science.

[11]  B. Fowler,et al.  Occupational Diseases: New Workforces, New Workplaces , 1989, Annals of the New York Academy of Sciences.

[12]  N Ito,et al.  Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats--an approach for a new medium-term bioassay system. , 1988, Carcinogenesis.

[13]  M. Tatematsu,et al.  Immunohistochemical demonstration of pyloric gland-type cells with low-pepsinogen isozyme 1 in preneoplastic and neoplastic tissues of rat stomachs treated with N-methyl-N'-nitro-N-nitrosoguanidine. , 1987, Journal of the National Cancer Institute.

[14]  S. Otani,et al.  Induction of ornithine decarboxylase in guinea-pig lymphocytes. Synergistic effect of diacylglycerol and calcium. , 1985, European journal of biochemistry.

[15]  G. Pershagen,et al.  Carcinomas of the respiratory tract in hamsters given arsenic trioxide and/or benzo[a]pyrene by the pulmonary route. , 1984, Environmental research.

[16]  E. Marafante,et al.  Tissue distribution and retention of74As-dimethylarsinic acid in mice and rats , 1984 .

[17]  A. Léonard Recent advances in arsenic mutagenesis and carcinogenesis , 1984 .

[18]  J. Chmiel,et al.  Capability of urinary components to enhance ornithine decarboxylase activity and promote urothelial tumorigenicity. , 1983, Cancer research.

[19]  A. Albores,et al.  Chronic Arsenic Poisoning in the North of Mexico , 1983, Human toxicology.

[20]  J. Cuzick,et al.  Medicinal arsenic and internal malignancies. , 1982, British Journal of Cancer.

[21]  S. Fukushima,et al.  HISTOPATHOLOGICAL ANALYSIS OF PRENEOPLASTIC CHANGES DURING N‐BUTYL‐N‐(4‐HYDROXYBUTYL)‐ NITROSAMINE‐INDUCED URINARY BLADDER CARCINOGENESIS IN RATS , 1982, Acta pathologica japonica.

[22]  J. T. Young Histopathologic examination of the rat nasal cavity. , 1981, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[23]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  A. Pegg,et al.  Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. , 1981, The Journal of biological chemistry.

[25]  M. Tatematsu,et al.  The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. , 1980, Gan.

[26]  伊東 信行 The Effects of Various Chemicals on the Development of Hyperplastic Liver Nodules in Hepatectomized Rats Treated with N-Nitrosodiethylamine or N-2-Fluorenylacetamide , 1980 .

[27]  M. Vahter,et al.  Metabolism of 74As-labeled trivalent and pentavalent inorganic arsenic in mice. , 1980, Environmental research.

[28]  E. Crecelius Changes in the chemical speciation of arsenic following ingestion by man. , 1977, Environmental health perspectives.

[29]  S. Wagner,et al.  Arsenic in blood and urine of forest workers as indices of exposure to cacodylic acid. , 1974, Archives of environmental health.

[30]  R. Braman,et al.  Methylated Forms of Arsenic in the Environment , 1973, Science.

[31]  S. Horiguchi,et al.  Renal lesions induced in F344/DuCrj rats by 4-weeks oral administration of dimethylarsinic acid. , 1993, Toxicology letters.

[32]  S. Fukushima,et al.  Effects of sodium nitrite and catechol, 3-methoxycatechol, or butylated hydroxyanisole in combination in a rat multiorgan carcinogenesis model. , 1993, Cancer research.

[33]  S. Horiguchi,et al.  Dimethylarsenic acid induces tetraploids in Chinese hamster cells , 1992, Bulletin of environmental contamination and toxicology.

[34]  S. Fukushima,et al.  Medium-term bioassay for carcinogens using multiorgan models. , 1991, Progress in experimental tumor research.

[35]  H. Katayama,et al.  Correlative histochemical studies on preneoplastic and neoplastic lesions in the kidney of rats treated with nitrosamines , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[36]  J. P. McGowan,et al.  Tumorigenic effect of sodium arsenite in rat kidney. , 1983, Proceedings of the Western Pharmacology Society.

[37]  T. Sh,et al.  Tumorigenic effect of sodium arsenite in rat kidney. , 1983 .

[38]  H. Roels,et al.  Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man , 1981, International archives of occupational and environmental health.

[39]  T. Inamasu,et al.  [Experimental study on carcinogenicity of beryllium oxide and arsenic trioxide to the lung of rats by an intratracheal instillation (author's transl)]. , 1980, Fukuoka igaku zasshi = Hukuoka acta medica.

[40]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.